SCHEMBL25539342

SCHEMBL25539342

CC1(C)c2ccc(-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccccc5-c5ccc6ccccc6c5)n4)c4ccccc34)cc2-c2cc3ccccc3cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
CTRC Q99895 1/20 0.37
MEN1 O00255 6/20 0.34
KMT2A Q03164 6/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 2/20 0.34
ACACA Q13085 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
CYP1A2 P05177 3/20 0.33
MET P08581 1/20 0.32
PIM1 P11309 1/20 0.32
GPR84 Q9NQS5 1/20 0.32
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32
RXRA P19793 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25538816 0.96 CYP1A1 (0.41) CYP1A1CYP1B1CTRCMEN1KMT2A
SCHEMBL25539316 0.96 ACACA (0.38) CYP1A1CYP1B1CTRCMEN1KMT2A
SCHEMBL25540281 0.95 ACACA (0.37) CYP1A1CYP1B1CTRCMEN1KMT2A
SCHEMBL25540440 0.95 ACACA (0.37) CYP1A1CYP1B1CTRCMEN1KMT2A
SCHEMBL25539324 0.95 ACACA (0.37) CYP1A1CYP1B1CTRCMEN1KMT2A
SCHEMBL25539332 0.95 CYP1A1 (0.45) CYP1A1CYP1B1CTRCMEN1KMT2A
SCHEMBL25540285 0.94 CYP1A1 (0.44) CYP1A1CYP1B1CTRCMEN1KMT2A
SCHEMBL25539337 0.94 CYP1A1 (0.41) CYP1A1CYP1B1CTRCMEN1KMT2A
SCHEMBL25540127 0.93 ACACA (0.36) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25539314 0.92 MEN1 (0.39) CYP1A1CYP1B1CTRCMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM CYP1A1 888/4885CYP1B1 1273/4885CTRC 3942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.